A detailed history of Advisors Asset Management, Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 12,762 shares of FLGT stock, worth $220,910. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,762
Previous 12,884 0.95%
Holding current value
$220,910
Previous $252,000 9.92%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$19.6 - $25.06 $2,391 - $3,057
-122 Reduced 0.95%
12,762 $277,000
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $3,932 - $4,649
206 Added 1.62%
12,884 $252,000
Q1 2024

May 14, 2024

SELL
$21.55 - $29.29 $5,322 - $7,234
-247 Reduced 1.91%
12,678 $275,000
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $157,702 - $201,931
6,671 Added 106.67%
12,925 $373,000
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $178,364 - $254,537
6,254 New
6,254 $231,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $524M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.